Multidrug resistance in anaerobes - PubMed (original) (raw)
Review
Multidrug resistance in anaerobes
Lyudmila Boyanova et al. Future Microbiol. 2019 Aug.
Abstract
Multidrug resistance (MDR) in anaerobes is not a well-known topic. Bacteroides fragilis group isolates have numerous resistance determinants such as multidrug efflux pumps, cfiA and nimB genes and activating insertion sequences, and some isolates exhibited extensive drug-resistant patterns. MDR rates in B. fragilis group were from 1.5 to >18% and up to >71% in cfiA and nimB positive isolates carrying insertion sequences. MDR was present in >1/2 of Clostridioides difficile isolates, most often in epidemic/hypervirulent strains and unusually high metronidazole or vancomycin resistance has been reported in single studies. MDR was found in Prevotella spp. (in ≤10% of isolates), Finegoldia magna, Veillonella spp. and Cutibacterium acnes. Resistance in the anaerobes tends to be less predictable and anaerobic microbiology is required in more laboratories. New hopes may be new antibiotics such as eravacycline, cadazolid, surotomycin, ridinilazol or C. difficile toxoid vaccines; however, more efforts are needed to track the MDR in anaerobes.
Keywords: anaerobes; anaerobic cocci; mechanisms; multidrug resistance; prevalence; rates.
Similar articles
- PCR-based detection of resistance genes in anaerobic bacteria isolated from intra-abdominal infections.
Tran CM, Tanaka K, Watanabe K. Tran CM, et al. J Infect Chemother. 2013 Apr;19(2):279-90. doi: 10.1007/s10156-012-0532-2. Epub 2013 Jan 22. J Infect Chemother. 2013. PMID: 23338012 - Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Roberts SA, et al. J Antimicrob Chemother. 2006 May;57(5):992-8. doi: 10.1093/jac/dkl052. Epub 2006 Feb 28. J Antimicrob Chemother. 2006. PMID: 16507560 - Antimicrobial susceptibility and clinical findings of significant anaerobic bacteria in southern Spain.
Cobo F, Rodríguez-Granger J, Pérez-Zapata I, Sampedro A, Aliaga L, Navarro-Marí JM. Cobo F, et al. Anaerobe. 2019 Oct;59:49-53. doi: 10.1016/j.anaerobe.2019.05.007. Epub 2019 May 16. Anaerobe. 2019. PMID: 31103531 - Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades.
Boyanova L, Kolarov R, Mitov I. Boyanova L, et al. Anaerobe. 2015 Feb;31:4-10. doi: 10.1016/j.anaerobe.2014.05.004. Epub 2014 May 27. Anaerobe. 2015. PMID: 24875330 Review. - Anaerobic resistance: should we be worried?
Cooley L, Teng J. Cooley L, et al. Curr Opin Infect Dis. 2019 Dec;32(6):523-530. doi: 10.1097/QCO.0000000000000595. Curr Opin Infect Dis. 2019. PMID: 31567734 Review.
Cited by
- In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria.
Umemura T, Hagihara M, Mori T, Mikamo H. Umemura T, et al. Antibiotics (Basel). 2022 Feb 22;11(3):292. doi: 10.3390/antibiotics11030292. Antibiotics (Basel). 2022. PMID: 35326756 Free PMC article. - In-Silico Tool for Predicting, Scanning, and Designing Defensins.
Kaur D, Patiyal S, Arora C, Singh R, Lodhi G, Raghava GPS. Kaur D, et al. Front Immunol. 2021 Nov 22;12:780610. doi: 10.3389/fimmu.2021.780610. eCollection 2021. Front Immunol. 2021. PMID: 34880873 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous